CELZ
- Creative Medical Technology Holdings, Inc.
()
Overview
Company Summary
Creative Medical Technology Holdings, Inc. (CELZ) is a biotechnology company that focuses on developing and commercializing innovative stem cell-based therapies and technologies. The company's primary objective is to address unmet medical needs in various areas, including urology, oncology, neurology, orthopedics, and dermatology.
CELZ primarily operates through its subsidiary, Creative Medical Health, Inc., which holds a portfolio of patents and intellectual property related to stem cell technology. The company's research and development efforts are centered around utilizing adult stem cells, specifically mesenchymal stem cells (MSCs), to develop potential treatments for different medical conditions and diseases.
One notable area of focus for CELZ is regenerative medicine, aiming to restore normal function to damaged or diseased tissues by using the patient's own stem cells. The company employs proprietary techniques to isolate and expand MSCs, allowing for large-scale manufacturing and therapeutic applications in a variety of medical fields.
In addition to their research endeavors, CELZ is also involved in developing companion diagnostics and implementing next-generation sequencing platforms. These allow for the identification and isolation of specific genetic markers associated with targeted medical conditions, thereby enabling personalized and precise treatment strategies.
Overall, Creative Medical Technology Holdings, Inc. is dedicated to advancing the field of regenerative medicine and harnessing the therapeutic potential of stem cells to create innovative and effective treatments for a wide range of medical conditions.